Abstract Summary
The physiological haemostasis comprises a balance between the formation and the breakdown of a clot at the right time and the right location. The essential parts of this process are formed by enough and well functioning platelets, that will upon activation close the rupture in de vessel wall. Furthermore, the coagulation process is initiated with the formation of a fibrin clot, a process that is controlled by the endogenous anticoagulation. Finally, the fibrinolysis breaks down this clot. All these processes and their interaction are described in this paper.
Samenvatting
De fysiologie van de hemostase omvat een precair evenwicht waarbij een stolsel op het juiste moment en op de juiste plaats moeten worden gevormd en afgebroken. De essentiële onderdelen van dit proces worden gevormd door voldoende en goed functionerende bloedplaatjes die aanvankelijk het gat in de bloedvatwand dichten. Daar bovenop wordt de stolling geïnitieerd met de vorming van een fibrinestolsel en dit proces wordt gecontroleerd door de endogene antistolling. Dit stolsel wordt vervolgens afgebroken door de fibrinolyse. De verschillende processen en hun interactie worden in dit artikel beschreven.
Similar content being viewed by others
Literatuur
Lowe G. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb. 2003;33:455-7.
Carmeliet P, Collen D. Development and disease in proteinase-deficient mice. Role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res. 1998;91:255-85.
Remick D. Biological perspectives. Pathophysiology of sepsis. Am J Pathol. 2007;170:1435-44.
Staton C, Lewis C. Angiogenesis inhibitors found within the haemostasis pathway. J Cell Mol Med. 2005;9:286-302.
Mügge A, Förstermann U, Lichtlen PR. Platelets, endothelium-dependent responses and atherosclerosis. Ann Med. 1991; 23:545-50.
Hermann M. Cyclooxygenase-2 and nitric oxide. J Cardiovasc Pharmacol. 2006;47:S21-5.
Opal SM, Kessler CM, Roemisch J, Knaub S. Antithrombin, heparin, and heparin sulfate. Crit Care Med. 2002;30:S325-31.
Dahlbäck B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol. 2005;25:1311-20.
Lijnen HR, Collen D. Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis. 1997;39:343-50.
Sumpio BE, Riley JT, Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002;34:1508-12.
Geet C van. Thrombopoiesis: new concepts. Verh K Acad Geneeskd Belg. 2004;66:5-24.
Geet C van, Freson K, Vos R de, Vermylen J. Hereditary thrombocytopenias. In: Gresele P, Page CP, Fuster V, Vermylen J, eds. Platelets in thrombotic and non-thrombotic disorders. Pathophysiology, pharmacology and therapeutics. Cambridge University Press, 2002. p. 515-27.
Geet C van, Freson K. The production of platelets. In: Arnout J, Gaetano G de, Hoylaerts M, et al., eds. Thrombosis: fundamental and clinical aspects. Leuven University Press, 2003. p. 16-36.
Gibbins JM. Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci. 2004;117:3415-25.
Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res. 2004;114:447-53.
Groot E, Groot PG de, Fijnheer R, Lenting PJ. The presence of active von Willebrand factor under various pathological conditions. Curr Opin Hematol. 2007;14:284-9.
Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res. 2006;99:1293-304.
Bearer EL, Prakash JM, Li Z. Actin dynamics in platelets. Int Rev Cytol. 2002;217:137-82.
Reed GL. Platelet secretory mechanisms. Semin Thromb Hemost. 2004;30:441-50.
Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31:381-92.
Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-65.
Hoffman M, Monroe DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis. 1998;9:S61-5.
Mann KG. Thrombin formation. Chest. 2003;124:4S-10.
Schearer MJ. Vitamin K metabolism and nutriture. Blood Rev. 1992;6:92-104.
Lwaleed BA, Bass PS. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol. 2006;208: 327-39.
Esmon CT. The protein C pathway. Chest. 2003;124:26-32.
Booth NA. Fibrinolysis and thrombosis. Baillieres Best Pract Res Clin Haematol. 1999;12:423-33.
Author information
Authors and Affiliations
Corresponding author
Additional information
Prof. dr. Chris van Geet, afdeling Kindergeneeskunde (Hemato-oncologie), Universitair Ziekenhuis Leuven, en Centrum voor Moleculaire en Vasculaire Biologie, ku Leuven. Prof. ir. Kathleen Freson, Centrum voor Moleculaire en Vasculaire Biologie, ku Leuven.
Correspondentieadres: Prof. dr. C. van Geet, afdeling Kindergeneeskunde (Hemato-oncologie), Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven
Rights and permissions
About this article
Cite this article
van Geet, C., Freson, K. Fysiologie van de hemostase. KIND 75, 176–180 (2007). https://doi.org/10.1007/BF03061690
Issue Date:
DOI: https://doi.org/10.1007/BF03061690